Teligent Surprised By Orphan Generic Setback

FDA Wants More Information On Complex Generic

 
• By Aidan Fry
  
Oliver_Twist
Teligent has suffered a setback in its bid to bring a generic of an orphan drug to the US market • Source: Shutterstock

More from Generics

More from Products